Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review
ConclusionsBased on current publications, the use of NOACs is at least non-inferior to warfarin in patients with AF and liver disease.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Cirrhosis | Coumadin | Databases & Libraries | Gastroenterology | Heart | Hemorrhagic Stroke | Liver | Liver Disease | Stroke | Study | Urology & Nephrology | Vitamin K | Vitamins | Warfarin